Page last updated: 2024-10-31

midazolam and Ureteral Obstruction

midazolam has been researched along with Ureteral Obstruction in 1 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Ureteral Obstruction: Blockage in any part of the URETER causing obstruction of urine flow from the kidney to the URINARY BLADDER. The obstruction may be congenital, acquired, unilateral, bilateral, complete, partial, acute, or chronic. Depending on the degree and duration of the obstruction, clinical features vary greatly such as HYDRONEPHROSIS and obstructive nephropathy.

Research Excerpts

ExcerptRelevanceReference
" The dosage of 0."1.32[Ureteroscopy under intravenous analgesia with remifentanil]. ( Karypiadou, M; Langen, PH; Steffens, J, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Langen, PH1
Karypiadou, M1
Steffens, J1

Other Studies

1 other study available for midazolam and Ureteral Obstruction

ArticleYear
[Ureteroscopy under intravenous analgesia with remifentanil].
    Der Urologe. Ausg. A, 2004, Volume: 43, Issue:6

    Topics: Carcinoma, Renal Cell; Conscious Sedation; Diagnosis, Differential; Dose-Response Relationship, Drug

2004